Latest Breaking News On - Disruptor funds - Page 1 : comparemela.com

Kineticos Ventures has been busy investing as well. In late May, eXmoor pharma, a UK cell and gene therapy manufacturer partner closed on a $35 million Series A round of funding from Kineticos and one other.

United kingdomJuly kincell bioShailesh maingiKincell bioKineticos life sciencesKineticos disruptor fundAccelerator fundKineticos venturesDisruptor fundsAntimicrobial resistanceInceptor bioKineticos ventures founderKineticos ventureLife sciences